vTv Therapeutics Files 8-K for Routine Disclosures
Ticker: VTVT · Form: 8-K · Filed: May 16, 2025 · CIK: 1641489
| Field | Detail |
|---|---|
| Company | Vtv Therapeutics Inc. (VTVT) |
| Form Type | 8-K |
| Filed Date | May 16, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: disclosure, regulatory-filing, financials
Related Tickers: VTVT
TL;DR
vTvT filed an 8-K, looks like standard procedure, check exhibits for hidden gems.
AI Summary
vTv Therapeutics Inc. filed an 8-K on May 16, 2025, primarily for a Regulation FD Disclosure and to file financial statements and exhibits. The filing does not appear to contain new material events or financial updates beyond routine disclosures.
Why It Matters
This filing indicates vTv Therapeutics is meeting its regulatory reporting obligations. Investors should review the exhibits for any potentially significant, albeit not explicitly stated, information.
Risk Assessment
Risk Level: low — The filing is a routine 8-K for disclosures and exhibits, not indicating any immediate material changes or negative events.
Key Players & Entities
- vTv Therapeutics Inc. (company) — Registrant
- May 16, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- High Point, NC (location) — Principal Executive Offices
FAQ
What is the primary purpose of this 8-K filing by vTv Therapeutics Inc.?
The primary purpose of this 8-K filing is for Regulation FD Disclosure and to file Financial Statements and Exhibits.
On what date was this 8-K report filed?
The report was filed on May 16, 2025.
Where are vTv Therapeutics Inc.'s principal executive offices located?
The principal executive offices are located at 3980 Premier Drive, Suite 310, High Point, NC 27265.
What is the SEC file number for vTv Therapeutics Inc.?
The SEC file number for vTv Therapeutics Inc. is 001-37524.
What is the Standard Industrial Classification code for vTv Therapeutics Inc.?
The Standard Industrial Classification code for vTv Therapeutics Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 16, 2025 regarding vTv Therapeutics Inc. (VTVT).